AORT – artivion, inc. (US:NASDAQ)

News

How The Investment Story Is Shifting For Artivion (AORT) After Recent Analyst And FDA Updates [Yahoo! Finance]
1 Stock Under $50 to Own for Decades and 2 We Avoid [Yahoo! Finance]
Artivion (AORT) was upgraded by LADENBURG THALM/SH SH from "neutral" to "buy". They now have a $42.00 price target on the stock.
Artivion Secures FDA Approval for NEXUS Aortic Arch System [Yahoo! Finance]
Artivion, ANI Pharmaceuticals, and Privia Health Shares Are Soaring, What You Need To Know [Yahoo! Finance]
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com